中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
33期
301-301,303
,共2页
间苯三酚%安宝%晚期先兆流产%疗效%不良反应
間苯三酚%安寶%晚期先兆流產%療效%不良反應
간분삼분%안보%만기선조유산%료효%불량반응
Late threatened abortion%Phloroglucinol%Anpo%Clinical curative effect%Adverse reactions
目的:观察间苯三酚联合安宝治疗晚期先兆流产的疗效。方法选择我院2011年至2013年120例,孕20~28周前晚期先兆流产患者,随机分为观察组及对照组各60例,观察组采用间苯三酚联合安宝治疗,对照组采用安宝治疗。观察两组患者疗效及不良反应。结果观察组总有效率93.33%;对照组总有效率81.67%;观察组治疗效果明显好于对照组,观察组不良反应发生率为10%;对照组不良反应发生率为31.6%;观察组不良反应发生率明显低于对照组,两组比较有显著性差异,有统计学意义P<0.05。结论间苯三酚联合安宝治疗先兆流产疗效显著,而且不良反应少,具有较高的安全性,值得临床推广。
目的:觀察間苯三酚聯閤安寶治療晚期先兆流產的療效。方法選擇我院2011年至2013年120例,孕20~28週前晚期先兆流產患者,隨機分為觀察組及對照組各60例,觀察組採用間苯三酚聯閤安寶治療,對照組採用安寶治療。觀察兩組患者療效及不良反應。結果觀察組總有效率93.33%;對照組總有效率81.67%;觀察組治療效果明顯好于對照組,觀察組不良反應髮生率為10%;對照組不良反應髮生率為31.6%;觀察組不良反應髮生率明顯低于對照組,兩組比較有顯著性差異,有統計學意義P<0.05。結論間苯三酚聯閤安寶治療先兆流產療效顯著,而且不良反應少,具有較高的安全性,值得臨床推廣。
목적:관찰간분삼분연합안보치료만기선조유산적료효。방법선택아원2011년지2013년120례,잉20~28주전만기선조유산환자,수궤분위관찰조급대조조각60례,관찰조채용간분삼분연합안보치료,대조조채용안보치료。관찰량조환자료효급불량반응。결과관찰조총유효솔93.33%;대조조총유효솔81.67%;관찰조치료효과명현호우대조조,관찰조불량반응발생솔위10%;대조조불량반응발생솔위31.6%;관찰조불량반응발생솔명현저우대조조,량조비교유현저성차이,유통계학의의P<0.05。결론간분삼분연합안보치료선조유산료효현저,이차불량반응소,구유교고적안전성,치득림상추엄。
Objective To observe the clinical efifcacy of late threatened abortion after 20 weeks by using Phloroglucinol and Anpo. Methods A total of 120 cases of late threatened abortion patients were chosen from the author’s hospital from 2011 to 2013, after 20 weeks to before 28 weeks, those who were divided randomLy into study and control groups of each 60 cases. The study group was given Phloroglucinol and Anpo;and the control group was given Anpo;then to observe these two groups on their clinical efifcacy and adverse reactions. Results The total effective rate of the study group was 93.33%, and the control group was 81.67%. After compared with the two groups, The total efifciency rate of the study group was signiifcantly higher than the control group (P<0.05). In the study group, adverse reaction on pregnant women was 10%, However, in the control group, it was 31.67%signiifcantly higher than the study group (P<0.05). Conclusion The Phloroglucinol and Anpo used on the late threatened abortion after 20 weeks is safety and effective and little adverse reactions, thus is worthy of clinical promotion.